T

Therafirst Medical Center | Fort Lauderdale, FL

Research site
(Unclaimed)
Location
4011 North Federal Hwy, Fort Lauderdale, Florida, United States of America
Site insights

Top conditions

HIV Infections (16 trials)

Infections (6 trials)

Acquired Immunodeficiency Syndrome (5 trials)

Communicable Diseases (4 trials)

Immunologic Deficiency Syndromes (3 trials)

Top treatments

Emtricitabine
Tenofovir Alafenamide
TAF
Bictegravir
Lenacapavir
Elvitegravir
TDF
Rilpivirine
Tenofovir Disoproxil Fumarate
Ritonavir

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

3 of 32
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
Study of Lenacapavir for HIV Pre-Exposure Prophylaxis in People Who Are at Risk for HIV Infection (PURPOSE 2)

The goal of this clinical study is to test how well the study drug, lenacapavir (LEN), works in preventing the risk of HIV.

Active, not recruiting
Pre-Exposure Prophylaxis of HIV Infection
Drug: Oral Lenacapavir (LEN)
Drug: F/TDF

The goal of this clinical study is to learn more about the effects of switching to the study drugs, bictegravir (BIC) plus lenacapavir (LEN), versus...

Enrolling
HIV-1-infection
Drug: Bictegravir
Drug: BIC/LEN FDC

The goal of this clinical study is to learn more about the effects of switching to the study drugs, bictegravir (BIC)/lenacapavir (LEN), fixed-dose c...

Enrolling
HIV-1-infection
Drug: B/F/TAF
Drug: Placebo to match B/F/TAF

Trial sponsors

Gilead Sciences logo

Gilead Sciences (19 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems